137 related articles for article (PubMed ID: 15732862)
21. Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats.
Ribeiro FV; César-Neto JB; Nociti FH; Sallum EA; Sallum AW; De Toledo S; Casati MZ
J Periodontol; 2006 Oct; 77(10):1731-5. PubMed ID: 17032117
[TBL] [Abstract][Full Text] [Related]
22. Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats.
Villegas I; Alarcón de la Lastra C; Martín MJ; Motilva V; La Casa García C
Pharmacology; 2002 Oct; 66(2):68-75. PubMed ID: 12207113
[TBL] [Abstract][Full Text] [Related]
23. Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.
Gurgel BCV; Almeida KT; Peixoto RF; Lima KC; Kantovitz KR; Humberto F; Toledo S
Braz Dent J; 2017; 28(2):135-139. PubMed ID: 28492740
[TBL] [Abstract][Full Text] [Related]
24. The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.
Feitosa DS; Marques MR; Casati MZ; Sallum EA; Nociti FH; de Toledo S
J Periodontal Res; 2009 Aug; 44(4):472-8. PubMed ID: 18973522
[TBL] [Abstract][Full Text] [Related]
25. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats.
Lima V; Vidal FD; Rocha FA; Brito GA; Ribeiro RA
J Periodontol; 2004 Jan; 75(1):162-8. PubMed ID: 15025228
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-2 may be involved with increased bone loss associated with experimental periodontitis and smoking: a study in rats.
César Neto JB; de Souza AP; Barbieri D; Moreno H; Sallum EA; Nociti FH
J Periodontol; 2004 Jul; 75(7):995-1000. PubMed ID: 15341358
[TBL] [Abstract][Full Text] [Related]
27. Micro-computerized tomography analysis of alveolar bone loss in ligature- and nicotine-induced experimental periodontitis in rats.
Liu YF; Wu LA; Wang J; Wen LY; Wang XJ
J Periodontal Res; 2010 Dec; 45(6):714-9. PubMed ID: 20572916
[TBL] [Abstract][Full Text] [Related]
28. Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.
Gupta YK; Chaudhary G; Sinha K
Can J Physiol Pharmacol; 2002 Mar; 80(3):210-7. PubMed ID: 11991232
[TBL] [Abstract][Full Text] [Related]
29. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats.
Verzeletti GN; Gaio EJ; Rösing CK
Acta Odontol Scand; 2007 Nov; 65(6):348-51. PubMed ID: 18071956
[TBL] [Abstract][Full Text] [Related]
30. [Selective cyclooxygenase-2 inhibitor].
Hettich M; Thomae K
Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
[No Abstract] [Full Text] [Related]
31. Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats.
Lin SK; Kok SH; Kuo MY; Wang TJ; Wang JT; Yeh FT; Hsiao M; Lan WH; Hong CY
Eur J Oral Sci; 2002 Jun; 110(3):246-53. PubMed ID: 12120711
[TBL] [Abstract][Full Text] [Related]
32. Disodium chlodronate prevents bone resorption in experimental periodontitis in rats.
Alencar VB; Bezerra MM; Lima V; Abreu AL; Brito GA; Rocha FA; Ribeiro RA
J Periodontol; 2002 Mar; 73(3):251-6. PubMed ID: 11924589
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.
Leitão RF; Ribeiro RA; Chaves HV; Rocha FA; Lima V; Brito GA
J Periodontol; 2005 Jun; 76(6):956-63. PubMed ID: 15948691
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis.
Lohinai Z; Stachlewitz R; Székely AD; Fehér E; Dézsi L; Szabó C
Life Sci; 2001 Dec; 70(3):279-90. PubMed ID: 12005261
[TBL] [Abstract][Full Text] [Related]
35. Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis.
Branco-de-Almeida LS; Franco GC; Castro ML; Dos Santos JG; Anbinder AL; Cortelli SC; Kajiya M; Kawai T; Rosalen PL
J Periodontol; 2012 May; 83(5):664-71. PubMed ID: 21966942
[TBL] [Abstract][Full Text] [Related]
36. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats.
Menezes AM; Rocha FA; Chaves HV; Carvalho CB; Ribeiro RA; Brito GA
J Periodontol; 2005 Nov; 76(11):1901-9. PubMed ID: 16274309
[TBL] [Abstract][Full Text] [Related]
37. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
[TBL] [Abstract][Full Text] [Related]
38. Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats.
Arantes RV; Cestari TM; Viscelli BA; Dionísio TJ; Garlet GP; Santos CF; de Assis GF; Taga R
J Periodontol; 2015 Jan; 86(1):162-72. PubMed ID: 25327303
[TBL] [Abstract][Full Text] [Related]
39. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model.
Hussey HJ; Tisdale MJ
Int J Cancer; 2000 Jul; 87(1):95-100. PubMed ID: 10861458
[TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes.
de Almeida JM; Theodoro LH; Bosco AF; Nagata MJ; Bonfante S; Garcia VG
J Periodontol; 2008 Nov; 79(11):2156-65. PubMed ID: 18980525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
